MediPal Holdings Corporation

MAHLY · OTC

Company research

MediPal Holdings Corporation (OTC: MAHLY) is a Tokyo-based Japanese healthcare distribution company founded in 1898 and one of Japan's leading wholesale distributors, operating across three core segments: Prescription Pharmaceutical Wholesale, Cosmetics/Daily Necessities/OTC Pharmaceutical Wholesale, and Animal Health Products and Food Processing Raw Materials Wholesale. The company serves a broad client base including hospitals, clinics, dispensing pharmacies, drugstores, supermarkets, convenience stores, animal hospitals, and processed food manufacturers through a nationwide network of over 300 distribution locations across Japan. Beyond its core distribution activities, MediPal provides a range of value-added services including post-marketing surveillance (PMS) for pharmaceutical manufacturers, contract-based epidemiological and clinical studies, computerized medical supply database management, health insurance claims review, and logistics outsourcing solutions. With approximately 13,061 full-time employees and annual revenues of approximately $24.7 billion, MediPal Holdings is a formidable force in Japan's healthcare supply chain, currently led by President and CEO Shuichi Watanabe and strategically expanding into higher-margin segments such as specialty pharmaceuticals and OTC products to reduce dependence on Japan's regulated prescription drug pricing environment.